Named as a key player in 33 of our reports, across 33 regions and countries.
| Market | Category | World size | Growth |
|---|---|---|---|
| KRAS Inhibitors | Pharmaceuticals | In full report | In full report |
Named as key players in the same markets as Revolution Medicines (number of shared markets).
Amgen Inc.1 shared market
Bristol-Myers Squibb1 shared market
Eli Lilly and Company1 shared market
Novartis AG1 shared market